Nonsynonymous variants in LRRK2 resulting in amino acid substitutions at positions 2019 and 1441 in the ROC/COR and kinase domains are known to cause LOPD, while regulatory variants of GAK have been shown to modulate PD risk across multiple ethnicities (9, 10). Here, LRRK2 is linked to Parkinson disease.